78 related articles for article (PubMed ID: 6532747)
1. [Malignant tumors and ABO blood groups--an analysis of 10,258 patients with malignant tumors].
Wan DS
Zhonghua Zhong Liu Za Zhi; 1984 Nov; 6(6):435-8. PubMed ID: 6532747
[No Abstract] [Full Text] [Related]
2. [Blood groups ABO, RHo(D) factor and the life expectancy of patients with malignant tumors].
Pejchl S; Chaloupka F
Vnitr Lek; 1984 Apr; 30(4):351-5. PubMed ID: 6428045
[No Abstract] [Full Text] [Related]
3. Malignant neoplasms and ABO blood groups--a short report.
Rahim MA; Rahman MH; Shahidullah M; Sarma SK
Bangladesh Med Res Counc Bull; 1979 Dec; 5(2):81-2. PubMed ID: 551768
[No Abstract] [Full Text] [Related]
4. [Blood groups and malignant tumor morbidity].
Zhivetskiĭ AV; Andrusenko VA; Bodnar' GV
Vrach Delo; 1976 Jun; (6):107-9. PubMed ID: 969438
[No Abstract] [Full Text] [Related]
5. Relationship between ABO blood groups and skin cancers.
Tursen U; Tiftik EN; Unal S; Gunduz O; Kaya TI; Camdeviren H; Ikizoglu G
Dermatol Online J; 2005 Dec; 11(3):44. PubMed ID: 16409940
[TBL] [Abstract][Full Text] [Related]
6. [ABO blood groups and malignant neoplasms].
Voĭtenko VP; Poliukhov AM; Kolodchenko VP; Rudakova NI
Genetika; 1977; 13(1):165-7. PubMed ID: 612480
[No Abstract] [Full Text] [Related]
7. [Is there a correlation between ABO blood groups, duodenal ulcer and some malignant diseases?].
Pazur M
Lijec Vjesn; 1973 Dec; 95(12):691-3. PubMed ID: 4775533
[No Abstract] [Full Text] [Related]
8. [Distribution of ABO blood groups in patients with carcinoma of the larynx, uterus, and with multiple neoplasms according to the records of the Department of Radiotherapy in the years 1960-1971].
Kukolewska-Machnicka J
Pol Przegl Radiol Med Nukl; 1973; 37(3):433-8. PubMed ID: 4720251
[No Abstract] [Full Text] [Related]
9. ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas.
Streiff MB; Segal J; Grossman SA; Kickler TS; Weir EG
Cancer; 2004 Apr; 100(8):1717-23. PubMed ID: 15073862
[TBL] [Abstract][Full Text] [Related]
10. Relationship of ABO blood groups to certain types of cancer common in Western India.
Jayant K
Indian J Cancer; 1971 Sep; 8(3):185-8. PubMed ID: 5141723
[No Abstract] [Full Text] [Related]
11. Pretreatment determination of isohaemagglutinin titter values in patients with malignant lymphomas and metastatic solid tumors.
Nikolić L; Budisin Z; Jelić S
Med Sci Monit; 2000; 6(1):63-7. PubMed ID: 11208285
[TBL] [Abstract][Full Text] [Related]
12. [Blood groups of the ABO system and survival rate in gynecologic tumors].
Marinaccio M; Traversa A; Carioggia E; Valentino L; Coviello M; Salamanna S; Dragone DC; Marinaccio L
Minerva Ginecol; 1995 Mar; 47(3):69-76. PubMed ID: 7630512
[TBL] [Abstract][Full Text] [Related]
13. Blood groups in cancer in Assam.
Baruah BD; Gogoi BC
Indian J Cancer; 1977 Mar; 14(1):6-9. PubMed ID: 885570
[No Abstract] [Full Text] [Related]
14. Distribution of blood groups in cancer.
Ghooi AM; Kamalpuria SK; Jain PK; Tandon PL
Indian J Cancer; 1970 Dec; 7(4):296-305. PubMed ID: 5518060
[No Abstract] [Full Text] [Related]
15. The blood group ABO gene transcript is down-regulated in human bladder tumors and growth-stimulated urothelial cell lines.
Orntoft TF; Meldgaard P; Pedersen B; Wolf H
Cancer Res; 1996 Mar; 56(5):1031-36. PubMed ID: 8640757
[TBL] [Abstract][Full Text] [Related]
16. [The relationship between the blood-groups ABO and Rho (D) factor and the frequency of malignant liver metastases (author's transl)].
Pejchl S; Chaloupka F
Cesk Gastroenterol Vyz; 1981 May; 35(3):105-11. PubMed ID: 6793244
[No Abstract] [Full Text] [Related]
17. [On the problem of the incidence of erythrocytes with changed ABO-antigenicity in hemoblastoses and malignant tumors].
Bártová A
Bibl Haematol; 1965; 23():330-6. PubMed ID: 5867124
[No Abstract] [Full Text] [Related]
18. ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: a single center experience of 221 patients.
Resnick IB; Tsirigotis PD; Shapira MY; Aker M; Bitan M; Samuel S; Abdul-Hai A; Ackerstein A; Or R; Slavin S
Biol Blood Marrow Transplant; 2008 Apr; 14(4):409-17. PubMed ID: 18342783
[TBL] [Abstract][Full Text] [Related]
19. [Blood groups (ABO system) as pathogenetic and risk factors in gynecological tumors].
Galeazzi L; Gualandri V
Minerva Ginecol; 1971 Feb; 23(3):144-7. PubMed ID: 5092552
[No Abstract] [Full Text] [Related]
20. Detection of blood group isoantigens A B and H in benign and malignant tumors of breast.
Sharma SM; Moghe KV
Indian J Pathol Microbiol; 1983 Jul; 26(3):177-80. PubMed ID: 6365762
[No Abstract] [Full Text] [Related]
[Next] [New Search]
